GSK acquires China’s Nanjing MeiRui Pharma for $70m
December 8, 2010Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing
GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …
William Vickery joins Hybrigenics
December 8, 2010Research and Development Hybrigenics, William Vickery, appointment, research and development
Paris-based biopharmaceutical company Hybrigenics has appointed William Vickery to the newly-created position of head of corporate and business development. He …
Astellas signs stem cell partnership in liver disease
December 8, 2010Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine
Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …
Out-of-hour procedures for clinical trials
December 8, 2010Research and Development GCP, Good Clinical Practice, Guy’s and St Thomas’ NHS Foundation Trust, Katherine Kennedy, clinical trials, trial safety
When a clinical trial subject is involved in a medical emergency, the hospital team need rapid access to information about …
NICE no for Avastin in breast cancer
December 8, 2010Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta
NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …
Contract research news in brief
December 8, 2010Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations
Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …
WPP launches Healix Digital Health
December 7, 2010Medical Communications Grey Healthcare, VML, WPP, digital marketing, digital marketing agency
A new digital healthcare agency, Healix Digital Health, has been launched by two companies within the WPP group. Grey Healthcare …
Trial hitch for Pfizer’s leukaemia drug submission plans
December 7, 2010Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia
Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …
WikiLeaks defends decision to publish critical facilities list
December 7, 2010Manufacturing and Production WikiLeaks, pharma manufacturing, security
Pharmaceutical facilities have featured prominently in in the latest batch of secret US embassy cables made public by WikiLeaks. The …
Takeda and Baxter make pandemic flu vaccine plans for Japan
December 7, 2010Manufacturing and Production Takeda, baxter, pharma manufacturing, vaccine manufacturing, vaccines
Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the …
AZ’s Brilique approved in Europe
December 7, 2010Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor
European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …
Pharma manufacturing news in brief
December 7, 2010Manufacturing and Production A5 Laboratories, Adamis Pharmaceuticals, Beximco Pharmaceuticals, Caraco Pharmaceutical, Genethon BioProd, Jiangsu Yanshen Biological Technology, Viva Pharmaceuticals, contract manufacturing, gene therapy
Our round-up of manufacturing updates includes the world’s first dedicated gene therapy facility, hefty fines for a Chinese drugmaker plus …
EU regulators launch fresh raids on pharma
December 7, 2010Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole
Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …
Laura Lane joins Black Swan
December 6, 2010Sales and Marketing Black Swan Analysis, Laura Lane, appointment, sales and marketing
Black Swan Analysis has appointed Dr Laura Lane to its Analysis and Forecasting team.Laura brings with her a strong scientific …
Roche’s MabThera successor shows phase II promise
December 6, 2010Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia
The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
Surprise exit for Pfizer chief executive Jeffrey Kindler
December 6, 2010Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession
Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
NICE recommends MabThera for non-Hodgkin’s lymphoma
December 6, 2010Sales and Marketing MabThera, NICE, Rituxan, Roche, non-Hodgkin’s lymphoma, rituximab
NICE has given a preliminary green-light to Roche’s MabThera for use as a maintenance therapy for non-Hodgkin’s lymphoma. The Institute’s …
A mature approach to relationships with pharma’s customers
December 6, 2010Sales and Marketing MSI, Paul Stuart Kregor, franchise management, pharma marketing
Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …
Apitope appoints Hayley French
December 6, 2010Research and Development, Sales and Marketing Apitope, Hayley French, appointment, research and development, sales and marketing
Belgium-based biopharmaceutical company Apitope has appointed Hayley French to its management team as commercial director. She will be responsible for …
Caligor Rx strengthens its European Team
December 3, 2010Research and Development Caligor Rx, Jacquelyn May, Jess McKenna, appointment, research and development
Clinical trial procurement firm Caligor Rx has appointed Jess McKenna head of quality assurance and customer relationships and Jacquelyn May …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
